Amelioration of osteogenesis in iPSC-derived mesenchymal stem cells from osteogenesis imperfecta patients by endoplasmic reticulum stress inhibitor
Publication date: 1 August 2021Source: Life Sciences, Volume 278Author(s): Thitinat Duangchan, Tulyapruek Tawonsawatruk, Chanika Angsanuntsukh, Objoon Trachoo, Suradej Hongeng, Narisorn Kitiyanant, Aungkura Supokawej
Source: Life Sciences - Category: Biology Source Type: research
More News: Biology | Osteogenesis Imperfecta (brittle bone disease) | Stem Cell Therapy | Stem Cells